Two Minutes in Trade - Key Pharma Definitions in the President's Section 232 Proclamation

This episode reviews the key definitions for pharmaceutical articles, patented pharmaceuticals, generic pharmaceuticals, and orphan drugs as provided in Annex I to the proclamation. Importers should begin to review their imports according to the tariff code listing and definitions in Annex I.

Listen to our Podcast

Customs & Import Compliance

Duty Savings, Tariff Mitigation & Supply Chain Efficiencies

Customs Audits & Enforcement

Litigation & Dispute Resolution

Government Relations & Trade Negotiations

Trade Remedies Advocacy

Export Compliance

Asia-Pacific Practice

Industries Served

Company

Firm News & Events

April 21, 2026 // TMIT Podcast

Two Minutes in Trade - Key Pharma Definitions in the President's Section 232 Proclamation

Professional

J. Nicole Bivens Collinson

Managing Principal, Operating Committee; International Trade & Government Relations Practice Leader

Services

Trade News & Resources

Training

Professionals

Professionals

About Us

Locations

April 21, 2026 // TMIT Podcast

Two Minutes in Trade - Key Pharma Definitions in the President's Section 232 Proclamation

Professional

J. Nicole Bivens Collinson

Managing Principal, Operating Committee; International Trade & Government Relations Practice Leader

Latest TMIT Podcast

Two Minutes in Trade - The Devil in the Details: BIS Implements the Section 232 Pharma Adjustment

Two Minutes in Trade - How Strait of Hormuz and Tariffs Are Raising Prices

Two Minutes in Trade - Auto Industry on Alert: Congress Looking at Section 232 Tariffs on the Auto Sector

Two Minutes in Trade - Section 122: More CAPE-able Tariff Refunds on the Way?

To receive ST&R Trade Report articles directly to your inbox

Cookie Consent